Advances in Electrochemical Sensing Modality in Cancer Research

Dear Colleagues,

Electrochemical detection modality has revolutionized fields of the life sciences, pharmaceutical industry, defense, agriculture, and environmental monitoring. Due to its facile sampling, inexpensive fabrication, high sensitivity and easy use, electrochemical-stemmed tools have also been applied to medical diagnostics and clinical management. As an example, blood glucose monitoring tools that integrate an enzymatic reaction with electrochemical detection modality are successfully utilized in our daily-live, expediting bed-side disease/health status monitoring. Moreover, standard tools have been adapted by multiple clinical and biological realms, including disease monitoring, theranostics, and companion diagnostics. In particular, cancer, a leading cause of death, has been a key focus of electrochemical sensing modalities for decades. Detecting cancer at an early stage is one of the most crucial steps for initiating successful treatment and control this malady, therefore increasing the survival rates of patients. Recent advances in electrochemical platforms with other emerging nano-technological modalities have accelerated cancer diagnostics and clinical management by detecting early cancer biomarkers, cancer cells, circulating cells/nuclear compartments, and exosomes through liquid biopsy sampling. This strategy therefore helps to provide an efficient diagnosis before the disease becomes incurable at later stages.

This Special Issue will include recent developments and advances in electrochemical sensing tools developed for cancer research, clinical management and cancer diagnosis. Emphasis will be on the applications of innovative hybrid electrochemical modalities in conjunction with optical platforms, wearable/attachable sensors, immunoassays, cyto-sensing, smart nanomaterials, aptamers, metamaterials, nano-imprinted surfaces, self-measuring approaches, and precision health approaches. From a cancer research perspective, we will also review circulating tumor cells/clusters, exosomes, volatile organic compounds, exposomes, and liquid biopsy techniques.

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Chemosensors is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• electro-optical platforms 
• wearable/attachable sensors 
• tattoo sensors
• immunosensors 
• cyto-sensing 
• smart nanomaterials 
• electrochemical metamaterials 
• graphene 
• carbon nanotubes 
• conducting polymers 
• nanoparticles 
• nano-imprinted surfaces 
• self-measuring approaches 
• precision health approaches 
• cancer cells 
• circulating tumor cells/clusters
• exosomes 
• volatile organic compounds 
• mobile health